Neuroligin-2-derived peptide-covered polyamidoamine-based (PAMAM) dendrimers enhance pancreatic β-cells' proliferation and functions.

Pancreatic β-cell membranes and presynaptic areas of neurons contain analogous protein complexes that control the secretion of bioactive molecules. These complexes include the neuroligins (NLs) and their binding partners, the neurexins (NXs). It has been recently reported that both insulin secretion and the proliferation rates of β-cells increase when cells are co-cultured with full-length NL-2 clusters. The pharmacological use of full-length protein is always problematic due to its unfavorable pharmacokinetic properties. Thus, NL-2-derived short peptide was conjugated to the surface of polyamidoamine-based (PAMAM) dendrimers. This nanoscale composite improved β-cell functions in terms of the rate of proliferation, glucose-stimulated insulin secretion (GSIS), and functional maturation. This functionalized dendrimer also protected β-cells under cellular stress conditions. In addition, various novel peptidomimetic scaffolds of NL-2-derived peptide were designed, synthesized, and conjugated to the surface of PAMAM in order to increase the biostability of the conjugates. However, after being covered by peptidomimetics, PAMAM dendrimers were inactive. Thus, the original peptide-based PAMAM dendrimer is a leading compound for continued research that might provide a unique starting point for designing an innovative class of antidiabetic therapeutics that possess a unique mode of action.

[1]  A. Sinclair,et al.  Type 2 diabetes mellitus in older people: a brief statement of key principles of modern day management including the assessment of frailty. A national collaborative stakeholder initiative , 2018, Diabetic medicine : a journal of the British Diabetic Association.

[2]  Jing Liu,et al.  Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. , 2018, International journal of pharmaceutics.

[3]  B. Ghosh,et al.  Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer , 2018, Artificial cells, nanomedicine, and biotechnology.

[4]  H. Senderowitz,et al.  Computer-Aided Design and Synthesis of 1-{4-[(3,4-Dihydroxybenzylidene)amino]phenyl}-5-oxopyrrolidine-3-carboxylic Acid as an Nrf2 Enhancer. , 2018, ChemPlusChem.

[5]  G. Booth,et al.  Evolving Trends in the Epidemiology, Risk Factors, and Prevention of Type 2 Diabetes: A Review. , 2018, The Canadian journal of cardiology.

[6]  Dawei Chen,et al.  Chondrocyte affinity peptide modified PAMAM conjugate as a nanoplatform for targeting and retention in cartilage. , 2018, Nanomedicine.

[7]  P. de Vos,et al.  Long-term viability and function of transplanted islets macroencapsulated at high density are achieved by enhanced oxygen supply , 2018, Scientific Reports.

[8]  Qi Wang,et al.  Dentromers, a Family of Super Dendrimers with Specific Properties and Applications , 2018, Molecules.

[9]  Yujie Zhang,et al.  Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release. , 2018, ACS applied materials & interfaces.

[10]  Nicholas A. Peppas,et al.  Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery , 2018, Acta pharmaceutica Sinica. B.

[11]  B. Sarmento,et al.  Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides , 2018, Peptides.

[12]  Axel Hollmann,et al.  Designing improved active peptides for therapeutic approaches against infectious diseases. , 2018, Biotechnology advances.

[13]  D. Na,et al.  Recent progress in dendrimer-based nanomedicine development , 2018, Archives of pharmacal research.

[14]  John Yu,et al.  Structure-based design for binding peptides in anti-cancer therapy. , 2018, Biomaterials.

[15]  M. Wang,et al.  Amino acids/peptides conjugated heterocycles: A tool for the recent development of novel therapeutic agents. , 2018, Bioorganic chemistry.

[16]  J. A. Nogueira-Machado,et al.  Cellular death, reactive oxygen species (ROS) and diabetic complications , 2018, Cell Death & Disease.

[17]  T. Matsui,et al.  Current knowledge of intestinal absorption of bioactive peptides. , 2017, Food & function.

[18]  John R. Petrie,et al.  Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms , 2017, The Canadian journal of cardiology.

[19]  G. Wilson,et al.  Novel Fusion Protein Targeting Mitochondrial DNA Improves Pancreatic Islet Functional Potency and Islet Transplantation Outcomes , 2017, Cell transplantation.

[20]  A. Saraswati,et al.  Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance. , 2017, Current medicinal chemistry.

[21]  G. Trapani,et al.  Peptides and their Metal Complexes in Neurodegenerative Diseases: from Structural Studies to Nanomedicine Prospects. , 2017, Current medicinal chemistry.

[22]  S. Shuto,et al.  From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane. , 2017, Chemistry.

[23]  T. Langer,et al.  Molecular Docking and 3D-Pharmacophore Modeling to Study the Interactions of Chalcone Derivatives with Estrogen Receptor Alpha , 2017, Pharmaceuticals.

[24]  P. Tufféry,et al.  Interfering peptides targeting protein-protein interactions: the next generation of drugs? , 2017, Drug discovery today.

[25]  A. Pic-Taylor,et al.  Integrated assessment of toxic effects of maghemite (γ-Fe2O3) nanoparticles in zebrafish. , 2017, Aquatic toxicology.

[26]  P. Mondal,et al.  Interventions to improve β-cell mass and function. , 2017, Annales d'endocrinologie.

[27]  J. R. Cardoso,et al.  Genotoxic and mutagenic assessment of iron oxide (maghemite-γ-Fe2O3) nanoparticle in the guppy Poecilia reticulata. , 2017, Chemosphere.

[28]  M. Peakman,et al.  Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it? , 2017, Diabetologia.

[29]  S. Lenzen.  Chemistry and biology of reactive species with special reference to the antioxidative defence status in pancreatic β-cells. , 2017, Biochimica et biophysica acta. General subjects.

[30]  Joël Richard.  Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects. , 2017, Therapeutic delivery.

[31]  Fabian J. Theis,et al.  Systematic single-cell analysis provides new insights into heterogeneity and plasticity of the pancreas , 2017, Molecular metabolism.

[32]  M. Igoillo-Esteve,et al.  Endoplasmic reticulum stress and eIF2α phosphorylation: The Achilles heel of pancreatic β cells , 2017, Molecular metabolism.

[33]  C. Cohrs,et al.  Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis , 2017, Molecular metabolism.

[34]  S. Ash,et al.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes , 2017, Clinical Reviews in Allergy & Immunology.

[35]  Arata Itoh,et al.  Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes , 2017, ImmunoTargets and therapy.

[36]  Guojun Chen,et al.  Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy. , 2017, Macromolecular bioscience.

[37]  Woo-Jin Song,et al.  The undoing and redoing of the diabetic β-cell. , 2017, Journal of diabetes and its complications.

[38]  Ekambaram Perumal,et al.  Neurobehavioural Toxicity of Iron Oxide Nanoparticles in Mice , 2017, Neurotoxicity Research.

[39]  K. Ye,et al.  Development of Islet Organoids from H9 Human Embryonic Stem Cells in Biomimetic 3D Scaffolds. , 2017, Stem cells and development.

[40]  R. Kulkarni,et al.  Exploring inter-organ crosstalk to uncover mechanisms that regulate β-cell function and mass , 2017, European Journal of Clinical Nutrition.

[41]  Daria Mochly-Rosen,et al.  Peptidomimetic therapeutics: scientific approaches and opportunities. , 2017, Drug discovery today.

[42]  H. Senderowitz,et al.  Mimicking Neuroligin-2 Functions in β-Cells by Functionalized Nanoparticles as a Novel Approach for Antidiabetic Therapy. , 2017, ACS applied materials & interfaces.

[43]  H. Karimian,et al.  Stimulation of β-adrenergic receptors plays a protective role via increased expression of RAF-1 and PDX-1 in hyperglycemic rat pancreatic islet (RIN-m5F) cells , 2016, Archives of medical science : AMS.

[44]  F. Urano,et al.  Endoplasmic reticulum stress in beta cells and autoimmune diabetes. , 2016, Current opinion in immunology.

[45]  M. Blaskovich.  Unusual Amino Acids in Medicinal Chemistry. , 2016, Journal of medicinal chemistry.

[46]  D. Vertommen,et al.  A New Oxopiperazin‐Based Peptidomimetic Molecule Inhibits Prostatic Acid Phosphatase Secretion and Induces Prostate Cancer Cell Apoptosis , 2016 .

[47]  M. Bugliani,et al.  Thrombospondin 1 protects pancreatic β-cells from lipotoxicity via the PERK–NRF2 pathway , 2016, Cell Death and Differentiation.

[48]  R. Scharfmann,et al.  Mass production of functional human pancreatic β‐cells: why and how? , 2016, Diabetes, obesity & metabolism.

[49]  N. Tang,et al.  Arginine–glycine–aspartic acid–polyethylene glycol–polyamidoamine dendrimer conjugate improves liver-cell aggregation and function in 3-D spheroid culture , 2016, International journal of nanomedicine.

[50]  Jing Wang,et al.  Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic β cells. , 2016, Cellular signalling.

[51]  K. Herold,et al.  Life and death of β cells in Type 1 diabetes: A comprehensive review. , 2016, Journal of autoimmunity.

[52]  K. Polonsky,et al.  Pancreatic β-Cell Death due to Pdx-1 Deficiency Requires Multi-BH Domain Protein Bax but Not Bak* , 2016, The Journal of Biological Chemistry.

[53]  L. Piemonti,et al.  The state of the art of islet transplantation and cell therapy in type 1 diabetes , 2016, Acta Diabetologica.

[54]  J. Prins,et al.  Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes. , 2016, Journal of molecular endocrinology.

[55]  J. Ludvigsson.  Therapies to Preserve β-Cell Function in Type 1 Diabetes , 2016, Drugs.

[56]  P. White,et al.  Advances in Fmoc solid‐phase peptide synthesis , 2016, Journal of peptide science : an official publication of the European Peptide Society.

[57]  Shewaye Lakew Mekuria,et al.  Preparation of self-assembled core-shell nano structure of conjugated generation 4.5 poly (amidoamine) dendrimer and monoclonal Anti-IL-6 antibody as bioimaging probe. , 2015, Colloids and surfaces. B, Biointerfaces.

[58]  D. Dhawan,et al.  Radiolabeling optimization and characterization of (68)Ga labeled DOTA-polyamido-amine dendrimer conjugate - Animal biodistribution and PET imaging results. , 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[59]  G. Lutty,et al.  Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[60]  D. Ucar,et al.  Transcriptional Regulation of the Pancreatic Islet: Implications for Islet Function , 2015, Current Diabetes Reports.

[61]  R. Thambiah.  Simulation of Beta-Adrenergic Receptors plays protective role via Increased expression of RAF-1 and PDX-1 in hyperglycemic Rat pancreatic Islet (RIN-m5F)cells , 2015 .

[62]  Clara L Santos-Cuevas,et al.  Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging. , 2015, Journal of nanoscience and nanotechnology.

[63]  L. Bouwens,et al.  Regulating the beta cell mass as a strategy for type-2 diabetes treatment. , 2015, Current drug targets.

[64]  T. Ishizaki,et al.  Protective effect of hydrogen sulfide on pancreatic beta-cells. , 2015, Nitric oxide : biology and chemistry.

[65]  C. Cras-Méneur,et al.  Natural history of β-cell adaptation and failure in type 2 diabetes. , 2015, Molecular aspects of medicine.

[66]  N. Kaiser,et al.  Beta cell response to nutrient overload involves phospholipid remodelling and lipid peroxidation , 2015, Diabetologia.

[67]  E. Cerasi,et al.  Benzothiazole derivatives augment glucose uptake in skeletal muscle cells and stimulate insulin secretion from pancreatic β-cells via AMPK activation. , 2014, Chemical communications.

[68]  J. Ong,et al.  Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells. , 2014, Molecular pharmaceutics.

[69]  P. Woster,et al.  Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites , 2014, Amino Acids.

[70]  K. Kono,et al.  Intracellular Environment-Responsive Stabilization of Polymer Vesicles Formed from Head-Tail Type Polycations Composed of a Polyamidoamine Dendron and Poly(l-lysine) , 2013, Molecules.

[71]  M. Hatanaka,et al.  Lost in translation: endoplasmic reticulum stress and the decline of β‐cell health in diabetes mellitus , 2013, Diabetes, obesity & metabolism.

[72]  Kamesh R. Ayasolla,et al.  Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress. , 2013, Journal of medicinal chemistry.

[73]  S. Chessler,et al.  Coculture analysis of extracellular protein interactions affecting insulin secretion by pancreatic beta cells. , 2013, Journal of visualized experiments : JoVE.

[74]  S. Chessler,et al.  Altered Pancreatic Islet Function and Morphology in Mice Lacking the Beta-Cell Surface Protein Neuroligin-2 , 2013, PloS one.

[75]  M. Pinent,et al.  Grape seed procyanidins improve β-cell functionality under lipotoxic conditions due to their lipid-lowering effect. , 2013, The Journal of nutritional biochemistry.

[76]  H. Byrne,et al.  Generation of intracellular reactive oxygen species and genotoxicity effect to exposure of nanosized polyamidoamine (PAMAM) dendrimers in PLHC-1 cells in vitro. , 2013, Aquatic toxicology.

[77]  Ying Luo,et al.  The effects of an RGD-PAMAM dendrimer conjugate in 3D spheroid culture on cell proliferation, expression and aggregation. , 2013, Biomaterials.

[78]  Angelo Bifone,et al.  In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry. , 2013, Molecular pharmaceutics.

[79]  Ya-hong Zhang,et al.  Antitumor effects and preliminary systemic toxicity of ANISpm in vivo and in vitro , 2013, Anti-cancer drugs.

[80]  J. Lehtiö,et al.  Thapsigargin down‐regulates protein levels of GRP78/BiP in INS‐1E cells , 2012, Journal of cellular biochemistry.

[81]  Meghan T. Miller,et al.  Transcellular Neuroligin-2 Interactions Enhance Insulin Secretion and Are Integral to Pancreatic β Cell Function* , 2012, The Journal of Biological Chemistry.

[82]  Yang Wang,et al.  The role of autophagy in endoplasmic reticulum stress-induced pancreatic β cell death , 2012, Autophagy.

[83]  C. Hampe.  Protective role of anti-idiotypic antibodies in autoimmunity – Lessons for type 1 diabetes , 2012, Autoimmunity.

[84]  T Mavromoustakos,et al.  Strategies in the rational drug design. , 2011, Current medicinal chemistry.

[85]  A. Fierabracci.  Peptide immunotherapies in Type 1 diabetes: lessons from animal models. , 2011, Current medicinal chemistry.

[86]  D. Scherman,et al.  Synthesis and application of lactosylated, 99mTc chelating albumin for measurement of liver function. , 2010, Bioconjugate chemistry.

[87]  K. Polonsky,et al.  Pdx1 and other factors that regulate pancreatic β‐cell survival , 2009, Diabetes, obesity & metabolism.

[88]  C. Ling,et al.  Mitochondrial dysfunction in pancreatic β-cells in Type 2 Diabetes , 2008, Molecular and Cellular Endocrinology.

[89]  P. Taylor,et al.  Expression of neurexin, neuroligin, and their cytoplasmic binding partners in the pancreatic beta-cells and the involvement of neuroligin in insulin secretion. , 2008, Endocrinology.

[90]  Roger A. Davis,et al.  Thioredoxin‐interacting protein deficiency induces Akt/Bcl‐xL signaling and pancreatic beta‐cell mass and protects against diabetes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  S. Lenzen.  Oxidative stress: the vulnerable beta-cell. , 2008, Biochemical Society transactions.

[92]  K. Zaret.  Faculty Opinions recommendation of Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. , 2008 .

[93]  R. Scharfmann,et al.  β Cells Can Be Generated from Endogenous Progenitors in Injured Adult Mouse Pancreas , 2008, Cell.

[94]  D. Eizirik,et al.  The role for endoplasmic reticulum stress in diabetes mellitus. , 2008, Endocrine reviews.

[95]  F Philipp Seib,et al.  Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[96]  E. Kroon,et al.  Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.

[97]  S. Kanba,et al.  Depletion of intracellular Ca2+ store itself may be a major factor in thapsigargin-induced ER stress and apoptosis in PC12 cells , 2006, Neurochemistry International.

[98]  R. Duncan,et al.  Dendrimer biocompatibility and toxicity. , 2005, Advanced drug delivery reviews.

[99]  Kai Sun,et al.  Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. , 2005, Nano letters.

[100]  B. Larijani,et al.  A review on the role of antioxidants in the management of diabetes and its complications. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[101]  Thommey P. Thomas,et al.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. , 2005, Cancer research.

[102]  P. B. Jensen,et al.  The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[103]  J. Schölmerich,et al.  Glucagon production of the rat insulinoma cell line INS-1-A quantitative comparison with primary rat pancreatic islets. , 2005, Biochemical and biophysical research communications.

[104]  Douglas A. Melton,et al.  Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation , 2004, Nature.

[105]  G. Webb,et al.  Abrogation of protein convertase 2 activity results in delayed islet cell differentiation and maturation, increased alpha-cell proliferation, and islet neogenesis. , 2003, Endocrinology.

[106]  R. Cortese,et al.  Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus. , 2002, Biochemistry.

[107]  R. Hampton.  ER stress response: Getting the UPR hand on misfolded proteins , 2000, Current Biology.

[108]  S. Lenzen,et al.  Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells , 1997, Diabetes.

[109]  F. Pociot,et al.  A20 Inhibits β-Cell Apoptosis by Multiple Mechanisms and Predicts Residual β-Cell Function in Type 1 Diabetes. , 2016, Molecular endocrinology.

[110]  Thierry Langer,et al.  LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..

[111]  R. Kaufman,et al.  A trip to the ER: coping with stress. , 2004, Trends in cell biology.

[112]  Andrea Guiotto,et al.  Conformational constraints of tyrosine in protein tyrosine kinase substrates: Information about preferred bioactive side‐chain orientation , 2003, Biopolymers.

[113]  D. Steiner,et al.  Clinical significance of circulating proinsulin and C-peptide. , 1976, Recent progress in hormone research.